RUA Life Sciences plc (RUA.L) LSE

Currency In GBp

AD

Valuation

Market Cap6.98M
Enterprise Value4.53M
P/E Ratio-82.61
PEG Ratio0.64
Price/Sales Ratio2.64
Price/Book Ratio1.65
Enterprise/Revenue2.22
Enterprise/EBITDA-25.81

Fiscal Year

Fiscal YearSeptember 30, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.03
Operating Margin-0.19
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.02

Income Statement

Revenue4.46M
Revenue/Share0.07
Gross Profit3.06M
EBITDA-383,335
Net Income-145,334
Diluted EPS-0

Balance Sheet

Total Cash3.25M
Total Cash/Share0.05
Total Debt1.35M
Total Debt/Equity0.19
Current Ratio4.64
Book Value Per Share0.12

Price History

52-Week Change44.71
52-Week High26.8
52-Week Low10.42
Moving Average 50 Days19.94
Moving Average 200 Days14.58

Statistics

Average Volume295,711
Shares Outstanding62.06M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateSeptember 01, 2003
AD